Care Ratings

₹1092.7 -8.3 | 0.8%

WEBSITE BSE:534804 NSE : CARERATING 10 May, 16:01

Market Cap ₹3264 Cr.

Stock P/E 32.4

P/B 4.6

Current Price ₹1092.7

Book Value ₹ 240.1

Face Value 10

52W High ₹1265

Dividend Yield 1.65%

52W Low ₹ 633.2

Edit Ratio

Care Ratings Research see more...

Equity Research: Care Ratings Ltd

Overview Inc. Year: 1993Industry: Ratings

CARE Ratings Ltd, a credit rating organization, presents diverse rating and grading services in India, Mauritius, and Nepal. The agency presents rating offerings for debt gadgets, inclusive of bonds, debentures, hybrid instruments, preference shares, fixed deposits, commercial papers and short-term debt applications, and certificate of deposits; and financial institution mortgage; financial region rating offerings, which cover banks, non-banking finance agencies, housing finance corporations, financial establishments, and so on.; structured finance ratings; coverage ratings; infrastructure quarter ratings; and public finance rating offerings that cover ratings of state authorities entities and urban infrastructure initiatives, as well as company governance ratings, project finance, and MLD valuation services. It offers corporate advisory, project evaluation and tracking, credit analytics, industry and company research, and due diligence and grading services, in addition to research and analytics to corporates, economic establishments, banks, and institutional traders. It was formerly known as Credit Analysis and Research Ltd and changed its name to CARE Ratings Ltd in June 2017. CARE Ratings Ltd become included in 1993 and is based in Mumbai, India.

Care Ratings Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Care Ratings Quarterly Results

#(Fig in Cr.)	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Net Sales	56	66	55	85	62	78	66	96	79	90
Other Income	7	7	8	8	12	10	12	11	14	10
Total Income	63	73	62	93	74	88	78	108	92	100
Total Expenditure	41	43	38	43	48	50	49	55	55	61
Operating Profit	22	30	24	50	25	38	29	53	37	39
Interest	0	0	0	0	0	1	0	0	0	0
Depreciation	2	2	2	3	3	3	3	3	3	3
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	20	27	21	48	23	34	26	50	34	36
Provision for Tax	5	4	7	13	6	14	8	14	10	12
Profit After Tax	15	23	14	35	16	20	18	36	24	25
Adjustments	-0	-0	-0	-1	-0	-1	-1	-1	-0	-0
Profit After Adjustments	15	23	14	34	16	20	18	35	23	24
Adjusted Earnings Per Share	4.9	7.7	4.6	11.6	5.4	6.6	6	11.8	7.9	8.1

Care Ratings Profit & Loss

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	203	236	261	279	287	333	319	244	248	248	279	331
Other Income	29	36	44	9	34	25	30	31	31	27	38	47
Total Income	232	271	304	288	321	358	349	275	280	275	317	378
Total Expenditure	68	88	101	105	105	122	144	162	153	168	180	220
Operating Profit	163	183	203	183	216	236	205	113	127	107	137	158
Interest	0	0	1	0	0	0	0	1	1	0	1	0
Depreciation	3	3	5	4	3	3	3	8	8	8	11	12
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	160	181	197	178	212	233	202	104	119	99	126	146
Provision for Tax	47	51	59	59	65	71	64	21	28	22	40	44
Profit After Tax	114	130	138	120	148	162	138	83	91	77	85	103
Adjustments	-0	-0	0	0	0	0	-1	-1	-1	-2	-2	-2
Profit After Adjustments	114	129	138	120	148	162	137	82	90	75	84	100
Adjusted Earnings Per Share	39.8	44.6	47.5	40.7	50.1	55.1	46.7	28	30.4	25.3	28.1	33.8

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	13%	5%	-3%	3%
Operating Profit CAGR	28%	7%	-10%	-2%
PAT CAGR	10%	1%	-12%	-3%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	66%	29%	3%	3%
ROE Average	13%	14%	17%	24%
ROCE Average	19%	19%	22%	34%

Care Ratings Balance Sheet

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	424	485	359	409	520	597	550	533	589	647	672
Minority's Interest	1	1	0	0	0	2	2	3	4	5	7
Borrowings	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	201	252	312	371	15	9	13	22	25	21	33
Total Current Liabilities	75	87	78	86	475	551	611	541	557	584	249
Total Liabilities	701	825	749	866	1010	1159	1177	1099	1175	1257	961
Fixed Assets	58	59	65	64	61	60	83	93	85	96	107
Other Non-Current Assets	348	447	501	593	83	257	252	229	40	65	61
Total Current Assets	295	319	184	209	866	842	842	777	1050	1096	793
Total Assets	701	825	749	866	1010	1159	1177	1099	1175	1257	961

Care Ratings Cash Flow

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	70	27	25	13	12	13	24	20	7	12	18
Cash Flow from Operating Activities	83	107	107	106	119	134	109	67	86	68	82
Cash Flow from Investing Activities	-87	-46	157	-41	-22	-25	83	27	-38	-27	13
Cash Flow from Financing Activities	-40	-62	-276	-66	-96	-99	-195	-107	-43	-35	-63
Net Cash Inflow / Outflow	-44	-1	-12	-1	1	11	-4	-13	5	6	32
Closing Cash & Cash Equivalent	27	25	13	12	13	24	20	7	12	18	49

Care Ratings Ratios

#	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	39.78	44.62	47.53	40.68	50.13	55.13	46.66	27.96	30.38	25.33	28.12
CEPS(Rs)	40.95	45.72	49.28	42.1	51.27	56.17	47.99	30.97	33.52	28.51	32.32
DPS(Rs)	20	28	79	28	28	55	30	19.5	17	17	25
Book NAV/Share(Rs)	148.57	166.88	121.46	138.53	176.5	199.65	179.42	173.02	191.49	215.75	224.16
Core EBITDA Margin(%)	66.3	62.7	61.24	62.24	63.39	63.35	54.76	33.38	38.55	32.15	35.61
EBIT Margin(%)	78.91	76.65	76.06	63.86	73.93	70.06	63.24	43.1	48	40.02	45.43
Pre Tax Margin(%)	78.91	76.65	75.56	63.86	73.93	70.06	63.24	42.72	47.76	39.83	45.07
PAT Margin (%)	55.98	55.03	52.9	42.81	51.36	48.8	43.29	34.26	36.61	31.03	30.63
Cash Profit Margin (%)	57.58	56.27	54.85	44.31	52.54	49.74	44.33	37.45	39.75	34.14	34.4
ROA(%)	20.1	16.99	17.52	14.82	15.74	14.97	11.82	7.34	8	6.32	7.71
ROE(%)	28.37	28.55	32.96	31.49	31.85	29.3	24.73	16.08	16.94	12.76	13.09
ROCE(%)	39.98	39.7	46.94	46.48	45.76	41.74	35.18	19.39	21.26	16.03	19.21
Receivable days	34.35	28.7	21.39	25.71	31.06	35.4	49.49	66.03	45.73	28	24.96
Inventory Days	0	0	0	0	0	0	0	0	0	0	0
Payable days	0	0	0	0	0	0	0	0	0	0	0
PER(x)	20.13	17.37	31.07	22.92	33.06	21.96	21.18	11.79	13.53	20.21	22.86
Price/Book(x)	5.39	4.65	12.16	6.73	9.39	6.06	5.51	1.9	2.15	2.37	2.87
Dividend Yield(%)	2.5	3.61	5.35	3	1.69	4.54	3.04	5.92	4.13	3.32	3.89
EV/Net Sales(x)	11.12	9.42	16.38	9.77	16.93	10.63	9.03	3.51	3.71	5.8	6.64
EV/Core EBITDA(x)	13.81	12.09	21	14.94	22.54	14.98	14.05	7.59	7.25	13.45	13.5
Net Sales Growth(%)	13.06	16.04	10.6	7.22	2.89	15.74	-4.12	-23.62	1.97	-0.33	12.66
EBIT Growth(%)	7.1	12.7	9.74	-9.98	19.11	9.69	-13.45	-47.94	13.56	-16.91	27.91
PAT Growth(%)	5.6	14.06	6.3	-13.22	23.42	9.97	-14.95	-39.54	8.97	-15.54	11.23
EPS Growth(%)	0	12.18	6.5	-14.41	23.24	9.97	-15.36	-40.08	8.67	-16.62	11.01
Debt/Equity(x)	0	0	0	0	0	0	0	0	0	0	0
Current Ratio(x)	3.93	3.67	2.34	2.43	1.82	1.53	1.38	1.44	1.88	1.88	3.19
Quick Ratio(x)	3.93	3.67	2.34	2.43	1.82	1.53	1.38	1.44	1.88	1.88	3.19
Interest Cover(x)	0	0	152.53	0	0	0	0	113.23	193.14	213.66	126.55
Total Debt/Mcap(x)	0	0	0	0	0	0	0	0	0	0	0

Care Ratings Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	0	0	0	0	0	0	0	0	0	0
FII	23.18	25.74	17.47	18.13	17.99	20.04	20.26	20.9	21.67	22.91
DII	16.1	14.52	21.53	24.88	25.06	23.8	23.17	23.73	26.32	26.89
Public	60.72	59.74	61	56.99	56.94	56.17	56.57	55.38	52.01	50.2
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

Pros

Company is almost debt free.

Cons

Promoter holding is low: 0%.
Company has a low return on equity of 14% over the last 3 years.
Stock is trading at 4.6 times its book value.
The company has delivered a poor profit growth of -12% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Care Ratings News

IPO

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	0	0	0	0	0	0	0	0	0	0
FII	0.69	0.76	0.52	0.54	0.53	0.6	0.6	0.62	0.65	0.68
DII	0.48	0.43	0.64	0.74	0.74	0.71	0.69	0.71	0.78	0.8
Public	1.8	1.77	1.81	1.69	1.69	1.67	1.68	1.65	1.55	1.5
Others	0	0	0	0	0	0	0	0	0	0
Total	2.96	2.96	2.96	2.96	2.96	2.97	2.97	2.98	2.98	2.99

Care Ratings

Add Watchlist

Care Ratings Research see more...

Overview Inc. Year: 1993Industry: Ratings

Care Ratings Share Price

Alert Data

Quarterly Price

Peer Comparison

Care Ratings Quarterly Results

Care Ratings Profit & Loss

Growth Rates

Care Ratings Balance Sheet

Care Ratings Cash Flow

Care Ratings Ratios

Care Ratings Shareholding Pattern

Care Ratings News

IPO

Stocx: India's #1 Marketplace to Find Your Winning Stock

Please Login!

Error!